Home Patent Forecast® Sectors Log In   Sign Up   Free Trial   Support   Contact   Pricing  
How it works Patent Forecast® Sectors Pricing Insights
Menu

Patent US0140287068
Inventor

!regextitle

Much More than Average Length Specification


1 Independent Claims

  • Claim 2. The hybrid cannabis plant, or an asexual clone of said hybrid cannabis plant, or a plant part, tissue, or cell thereof of claim 1 wherein the plant, plant part, tissue, or cell comprises a terpene oil content greater than about 1.5% by weight.
  • Claim 3. The hybrid cannabis plant, or an asexual clone of said hybrid cannabis plant, or a plant part, tissue, or cell thereof of claim 1, wherein the hybrid cannabis plant, or an asexual clone of said hybrid cannabis plant, or a plant part, tissue, or cell thereof comprises a tetrahydrocannabinol (THC) content that is at least 3.0% by weight as measured by GC-FID and calculated based on dry weight of the inflorescence.
  • Claim 4. The hybrid cannabis plant, or an asexual clone of said hybrid cannabis plant, or a plant part, tissue, or cell thereof of claim 1, wherein the hybrid cannabis plant, or an asexual clone of said hybrid cannabis plant, or a plant part, tissue, or cell thereof comprises a cannabidiol CBD content that is at least 3.0% by weight as measured by GC-FID and calculated based on dry weight of the inflorescence.
  • Claim 5. The hybrid cannabis plant, or an asexual clone of said hybrid cannabis plant, or a plant part, tissue, or cell thereof of claim 1, wherein the hybrid cannabis plant, or an asexual clone of said hybrid cannabis plant, or a plant part, tissue, or cell thereof comprises a tetrahydrocannabinol (THC) content that is at least 6.0% by weight as measured by GC-FID and calculated based on dry weight of the inflorescence.
  • Claim 6. The hybrid cannabis plant, or an asexual clone of said hybrid cannabis plant, or a plant part, tissue, or cell thereof of claim 1, wherein the hybrid cannabis plant, or an asexual clone of said hybrid cannabis plant, or a plant part, tissue, or cell thereof comprises a cannabidiol CBD content that is at least 6.0% by weight as measured by GC-FID and calculated based on dry weight of the inflorescence.
  • Claim 7. The hybrid cannabis plant, or an asexual clone of said hybrid cannabis plant, or a plant part, tissue, or cell thereof of claim 1, wherein limonene is the most abundant terpene in said terpene profile.
  • Claim 8. The hybrid cannabis plant, or an asexual clone of said hybrid cannabis plant, or a plant part, tissue, or cell thereof of claim 1, wherein terpinolene is the most abundant terpene in said terpene profile.
  • Claim 9. The hybrid cannabis plant, or an asexual clone of said hybrid cannabis plant, or a plant part, tissue, or cell thereof of claim 1, wherein alpha pinene is the most abundant terpene in said terpene profile.
  • Claim 10. The hybrid cannabis plant, or an asexual clone of said hybrid cannabis plant, or a plant part, tissue, or cell thereof of claim 1, wherein beta caryophyllene is the most abundant terpene in said terpene profile.
  • Claim 11. A method of breeding chemotype II cannabis plants with a non-myrcene dominant terpene profile, said method comprising: (i) making a cross between a first hybrid cannabis plant, or an asexual clone of said hybrid cannabis plant of claim 1 and a second cannabis plant to produce an F1 seed: (ii) harvesting the resulting seed(iii) growing said seedand (iv) selecting a cannabis plant with a desired phenotypewherein the resulting selected cannabis plant is a chemotype II cannabis plant with a non-myrcene dominant terpene profile.
  • Claim 12. A method of producing a chemotype II cannabis plant with a non-myrcene dominant terpene profile, said method comprising: (i) obtaining a cannabis seed, cutting, or plant cell, from a hybrid cannabis plant, or an asexual clone of said hybrid cannabis plant of claim 1(ii) placing said cannabis seed, cutting, or plant cell in an environment conducive to growthand (iii) allowing said cannabis seed, cutting, or plant cell to produce a cannabis plantwherein said produced cannabis plant is a chemotype II cannabis plant with a non-myrcene dominant terpene profile.
  • Claim 13. A cannabis extract from the hybrid cannabis plant, or an asexual clone of said hybrid cannabis plant, or a plant part, tissue, or cell thereof of claim 1.
  • Claim 15. An edible product comprising cannabis tissue from the hybrid cannabis plant, or an asexual clone of said hybrid cannabis plant, or a plant part, tissue, or cell thereof of claim 1.
  • Claim 17. The hybrid cannabis plant, or an asexual clone of said hybrid cannabis plant, or a plant part, tissue, or cell thereof of claim 1, wherein said plant part is selected from the group consisting of: trichomes, sun leaves, or inflorescences.


View Abstract and Specification Size

PDF with Images and Document Face >

Full Text Publication >



Patent Matrix® Search


USPTO Patent Document Number